Diana Mckenzie Biography and Net Worth

Director of agilon health

Diana L. McKenzie joined the agilon health board of directors in February 2023. Diana is a technology advisor, board member, and former Chief Information Officer with over thirty years of leadership experience gained from growing, scaling, and transforming global businesses in the Life Sciences and Software Industry with revenues ranging from $3-20B. She served as Workday’s first Chief Information Officer from 2016 to 2019. Before Workday, Diana served in multiple technology leadership roles at Amgen, Inc. from 2004-2016, including the role of Chief Information Officer. Prior to joining Amgen, she served in various technology leadership roles from 1987 to 2004 at Eli Lilly and Company.

Diana serves on MetLife, Inc., Vertex Pharmaceuticals, and Paradox boards and as a Special Advisor to Brighton Park Capital. She received her B.S. degree from Purdue University in 1986.

What is Diana Mckenzie's net worth?: The estimated net worth of Diana Mckenzie is at least $235,511.28 as of December 9th, 2024. Mckenzie owns 58,819 shares of agilon health stock worth more than $235,511 as of April 23rd. This net worth estimate does not reflect any other investments that Mckenzie may own. Learn More about Diana Mckenzie's net worth.
How do I contact Diana Mckenzie?: The corporate mailing address for Mckenzie and other agilon health executives is , , . agilon health can also be reached via phone at 562-256-3800 and via email at investor.relations@agilonhealth.com. Learn More on Diana Mckenzie's contact information.
Has Diana Mckenzie been buying or selling shares of agilon health?: Diana Mckenzie has not been actively trading shares of agilon health within the last three months. Most recently, on Monday, December 9th, Diana Mckenzie bought 7,500 shares of agilon health stock. The stock was acquired at an average cost of $2.20 per share, with a total value of $16,500.00. Following the completion of the transaction, the director now directly owns 58,819 shares of the company's stock, valued at $129,401.80. Learn More on Diana Mckenzie's trading history.
Who are agilon health's active insiders?: agilon health's insider roster includes Joan Danieley (Insider), Veeral Desai (Insider), Theodore Halkias (Insider), Benjamin Kornitzer (Insider), Diana Mckenzie (Director), Karen Mcloughlin (Director), Jeffrey Schwaneke (Director), Steven Sell (CEO), Benjamin Shaker (Insider), Michael Smith (Director), Glenn Sobotka (CAO), and John Wulf (Director). Learn More on agilon health's active insiders.
Are insiders buying or selling shares of agilon health?: During the last twelve months, agilon health insiders bought shares 5 times. They purchased a total of 110,000 shares worth more than $265,300.00. The most recent insider tranaction occured on December, 13th when Director Karen Mcloughlin bought 25,000 shares worth more than $55,000.00. Insiders at agilon health own 3.2% of the company. Learn More about insider trades at agilon health.
Information on this page was last updated on 12/13/2024.

Diana Mckenzie Insider Trading History at agilon health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/9/2024	Buy	7,500	$2.20	$16,500.00	58,819
11/25/2024	Buy	12,500	$2.28	$28,500.00	51,319

Diana Mckenzie Buying and Selling Activity at agilon health

agilon health Company Overview

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Today's Range

Now: $4.00

$3.94

$4.26

50 Day Range

MA: $4.16

$2.98

$5.69

2 Week Range

Now: $4.00

$1.50

$7.73

Volume

7,206,646 shs

Average Volume

4,784,899 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38